Contrast Media and Reactions — MCQs

Q: All of the following are used in a patient with decreased renal function (reduced GFR) to avoid contrast nephropathy except?

Mannitol. **Explanation:** Contrast-Induced Nephropathy (CIN) is a significant risk in patients with reduced GFR. The goal of management is to minimize renal vasoconstriction and oxidative stress. **Why Mannitol is the Correct Answer:** Historically, diuretics like **Mannitol** and Furosemide were thought to "flush" the kidneys. However, clinical trials (such as the PRINCE study) have shown that Mannitol is **ineffective** and may actually be **harmful**. It can cause osmotic diuresis leading to dehydration and further renal vasoconstriction, potentially worsening the risk of CIN. Therefore, it is no longer recommended. **Analysis of Other Options:** * **N-acetyl cysteine (NAC):** An antioxidant that scavenges free radicals and induces vasodilation. While its efficacy is debated in recent large trials (PRESERVE), it is still traditionally used in protocols to prevent CIN due to its low cost and safety profile. * **Fenoldopam:** A selective dopamine D1 receptor agonist that causes renal vasodilation. Though not routinely used due to cost and mixed evidence, it is pharmacologically intended to increase renal blood flow. * **Low Osmolar Contrast Media (LOCM):** High osmolar contrast (HOCM) is highly nephrotoxic. Switching to LOCM (e.g., Iohexol) or Iso-osmolar contrast (e.g., Iodixanol) significantly reduces the risk of CIN in high-risk patients. **High-Yield Clinical Pearls for NEET-PG:** * **Most effective preventive measure:** Adequate **Pre-procedure Hydration** with 0.9% Normal Saline is the gold standard. * **Definition of CIN:** An increase in serum creatinine of >0.5 mg/dL or >25% from baseline within 48–72 hours of contrast administration. * **Metformin:** Must be withheld for 48 hours *after* the procedure to avoid lactic acidosis if renal failure occurs.

Q: Which of the following conditions is associated with contrast nephropathy?

Diabetes nephropathy. **Explanation:** **Contrast-Induced Nephropathy (CIN)** is defined as an acute impairment of renal function (an increase in serum creatinine by >25% or >0.5 mg/dL) occurring within 48–72 hours of intravascular contrast administration. **Why Diabetes Nephropathy is the Correct Answer:** Diabetes mellitus, particularly when associated with pre-existing renal insufficiency (**Diabetic Nephropathy**), is the **single most significant independent risk factor** for developing CIN. The pathophysiology involves contrast-induced renal vasoconstriction leading to medullary ischemia and direct tubular cytotoxicity. In diabetic patients, the baseline oxidative stress and impaired vasodilatory capacity of the renal vasculature significantly potentiate these effects. **Analysis of Incorrect Options:** * **B, C, and D (Hypertension, Malignant Hypertension, Hypertensive Glomerulosclerosis):** While chronic hypertension can lead to renal damage, it is generally considered a secondary risk factor. Hypertension only significantly increases the risk of CIN if it has already progressed to significant **chronic kidney disease (CKD)** with a reduced Glomerular Filtration Rate (GFR). Diabetic nephropathy carries a much higher relative risk compared to hypertensive nephrosclerosis alone. **High-Yield Clinical Pearls for NEET-PG:** * **Most Important Risk Factor:** Pre-existing renal insufficiency (low GFR). * **Most Effective Prophylaxis:** Intravenous hydration with **Isotonic Saline (0.9% NaCl)** or Sodium Bicarbonate before and after the procedure. * **Metformin Warning:** Metformin does not cause CIN, but if CIN occurs, Metformin can accumulate and cause **Lactic Acidosis**. It should be withheld for 48 hours after contrast administration. * **Contrast Choice:** Non-ionic, **iso-osmolar** contrast media (e.g., Iodixanol) carry the lowest risk for nephropathy.

Q: Which of the following investigations must be performed before administering contrast to a patient?

Kidney function test (KFT). **Explanation:** The administration of iodinated contrast media (used in CT scans and angiography) poses a significant risk of **Contrast-Induced Nephropathy (CIN)**. CIN is defined as an acute decline in renal function (increase in serum creatinine by >0.5 mg/dL or >25% from baseline) within 48–72 hours of contrast exposure. Therefore, assessing the **Kidney Function Test (KFT)**—specifically **Serum Creatinine** and the **estimated Glomerular Filtration Rate (eGFR)**—is mandatory to screen for pre-existing renal impairment, which is the strongest risk factor for CIN. **Analysis of Incorrect Options:** * **Liver Function Test (LFT):** While some contrast agents are excreted via the biliary system, hepatic impairment does not significantly increase the risk of acute toxicity or contrast reactions. * **Urine Specific Gravity:** This measures urine concentration and hydration status but is an unreliable indicator of the kidney's ability to clear contrast media compared to eGFR. * **Serum Electrolytes:** While important for general patient management, electrolyte imbalances are not a direct contraindication to contrast nor a primary predictor of contrast-induced injury. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Threshold:** Contrast is generally considered safe if **eGFR >60 mL/min/1.73m²**. Caution is required if eGFR is between 30–60, and it is generally avoided (unless emergency) if **eGFR <30**. * **Prevention:** The most effective preventive measure for CIN is **intravenous hydration** with 0.9% Normal Saline before and after the procedure. * **Metformin:** In patients with renal impairment, Metformin should be withheld for 48 hours after contrast administration to prevent **Lactic Acidosis**. * **MRI Contrast:** For Gadolinium-based agents, the concern is **Nephrogenic Systemic Fibrosis (NSF)** in patients with severe renal failure.

Q: All of the following are true about iodinated intravascular contrast media except –

They are used in magnetic resonance imaging. **Explanation:** The correct answer is **D**. Iodinated contrast media are specifically designed for X-ray-based imaging modalities, not Magnetic Resonance Imaging (MRI). **1. Why Option D is the correct (false) statement:** Iodinated contrast agents work by increasing the attenuation of X-ray beams due to the high atomic number of Iodine ($Z=53$). MRI does not use X-rays; instead, it utilizes magnetic fields and radiofrequency pulses. The standard contrast agents for MRI are **Gadolinium-based contrast agents (GBCAs)**, which are paramagnetic and work by altering the relaxation times ($T1$ and $T2$) of nearby water protons. **2. Analysis of incorrect (true) options:** * **Option A:** Digital Subtraction Angiography (DSA) uses iodinated contrast injected into vessels to visualize lumen morphology by "subtracting" the overlying bone and soft tissue densities. * **Option B:** Iodine is highly **radio-opaque** (appears white on imaging) because it absorbs X-ray photons, providing the necessary contrast against blood and soft tissues. * **Option C:** These agents can cause **idiosyncratic (anaphylactoid) reactions**, ranging from mild urticaria to life-threatening bronchospasm and shock. Unlike true allergies, these are often not IgE-mediated. **Clinical Pearls for NEET-PG:** * **Contrast-Induced Nephropathy (CIN):** A key risk factor; defined as an increase in serum creatinine >0.5 mg/dL or >25% from baseline within 48–72 hours of administration. * **Pre-medication:** For patients with a history of prior reactions, use corticosteroids (e.g., Prednisolone) and H1 blockers. * **Osmolality:** Non-ionic, low-osmolar contrast media (LOCM) are preferred over high-osmolar media (HOCM) as they are safer and better tolerated. * **MRI Exception:** While rare, **Hepatobiliary agents** (like Primovist) are used in MRI, but they are still Gadolinium-based, never iodinated.

Q: Which of the following contrast media agents is least nephrotoxic?

Iodixanol. ### Explanation The primary determinant of contrast-induced nephropathy (CIN) is the **osmolality** of the contrast medium. High-osmolality agents cause renal vasoconstriction and direct tubular toxicity. **1. Why Iodixanol is Correct:** Iodixanol is a **non-ionic dimer** and is classified as an **Iso-osmolar Contrast Medium (IOCM)**. Its osmolality (approx. 290 mOsm/kg) is equal to that of human blood. Because it is isotonic to plasma, it causes the least amount of osmotic stress on the renal tubules, making it the least nephrotoxic option among those listed, especially in high-risk patients (e.g., diabetics with pre-existing renal impairment). **2. Analysis of Incorrect Options:** * **Diatrizoate & Metrizoate (Option B & C):** These are **Ionic Monomers** classified as **High-Osmolar Contrast Media (HOCM)**. Their osmolality is 5–8 times that of plasma (1500–2000 mOsm/kg). They carry the highest risk of nephrotoxicity and adverse allergic reactions. * **Ioxaglate (Option D):** This is an **Ionic Dimer** classified as a **Low-Osmolar Contrast Medium (LOCM)**. While safer than HOCM, its ionic nature and higher osmolality compared to Iodixanol make it more nephrotoxic than iso-osmolar agents. **3. NEET-PG High-Yield Pearls:** * **Classification by Osmolality:** * **HOCM:** Diatrizoate, Metrizoate, Iothalamate. * **LOCM:** Iohexol, Iopromide, Ioversol, Ioxaglate (Ionic). * **IOCM:** Iodixanol (Safest for kidneys). * **CIN Prevention:** The most effective preventive measure is **adequate hydration** (Normal saline) before and after the procedure. * **Risk Factor:** A baseline Serum Creatinine >1.5 mg/dL or eGFR <60 mL/min increases the risk of CIN. * **Metformin Rule:** Metformin should be withheld for 48 hours *after* contrast administration to prevent lactic acidosis if renal failure occurs.

Q: Worsening of kidney function in contrast nephropathy is best evaluated with?

High serum creatinine. **Explanation:** **Contrast-Induced Nephropathy (CIN)** is defined as an acute impairment of renal function following the intravascular administration of iodinated contrast media. **1. Why High Serum Creatinine is Correct:** Serum creatinine is the standard biochemical marker used to monitor glomerular filtration rate (GFR). In CIN, the contrast medium causes renal vasoconstriction and direct tubular toxicity, leading to a decrease in GFR. This results in a **rise in serum creatinine**, typically peaking within 3 to 5 days after contrast administration. A common diagnostic criterion for CIN is an absolute increase in serum creatinine of **≥0.5 mg/dL** or a relative increase of **≥25%** from the baseline value within 48–72 hours. **2. Why Incorrect Options are Wrong:** * **Low Serum Creatinine:** A decrease in creatinine would indicate improving renal function or muscle wasting, which is the opposite of what occurs in nephropathy. * **High/Low Serum Bilirubin:** Bilirubin is a marker of hepatobiliary function and hemolysis. It has no physiological correlation with contrast-induced renal injury or glomerular filtration. **Clinical Pearls for NEET-PG:** * **Risk Factor:** The single most important risk factor for CIN is pre-existing **chronic kidney disease (CKD)**, especially when associated with Diabetes Mellitus. * **Prevention:** The most effective preventive strategy is **adequate hydration** (usually with 0.9% Normal Saline) before and after the procedure. * **Contrast Choice:** Using **Non-ionic, Low-osmolar (LOCM)** or **Iso-osmolar** contrast media reduces the risk of CIN compared to high-osmolar agents. * **Metformin Note:** Metformin does not cause CIN, but if CIN occurs, metformin can accumulate and cause **lactic acidosis**. It should be withheld for 48 hours after the procedure in high-risk patients.

Q: A child undergoing CECT chest develops immediate swelling at the contrast injection site, progressing gradually. The child also reports numbness and pain on passive finger extension, and examination reveals a feeble radial pulse. What is the most appropriate next step?

Immediate fasciotomy. ### Explanation The clinical presentation describes a severe case of **Contrast Extravasation** leading to **Acute Compartment Syndrome**. **1. Why "Immediate Fasciotomy" is Correct:** The key clinical markers here are **pain on passive extension**, **numbness** (paresthesia), and a **feeble radial pulse**. These are the "Ps" of compartment syndrome. When contrast is injected under pressure (especially via power injectors in CECT), a large volume can enter the tight fascial compartments of the limb. This increases intracompartmental pressure, compromising capillary perfusion and leading to tissue ischemia. If neurovascular compromise is evident (feeble pulse, sensory loss), it is a surgical emergency requiring **immediate fasciotomy** to decompress the compartment and prevent permanent necrosis or Volkmann’s Ischemic Contracture. **2. Why Other Options are Incorrect:** * **A. High dose prednisolone and antihistamines:** These are used for *anaphylactoid* (hypersensitivity) reactions. They do not address the mechanical pressure/ischemia caused by extravasation. * **B. Angiography:** This would cause further delay and potentially involve more contrast injection, worsening the pressure. Diagnosis of compartment syndrome is primarily clinical. * **D. Surgical exploration:** While related, "exploration" is too vague. The specific life-and-limb-saving procedure required for compartment syndrome is a fasciotomy. **3. Clinical Pearls for NEET-PG:** * **Risk Factors:** Use of power injectors, small/fragile veins (infants/elderly), and unconscious patients who cannot report pain. * **Initial Management:** For *mild* extravasation, elevate the limb and apply cold compresses. * **The "6 Ps" of Compartment Syndrome:** Pain (out of proportion), Pallor, Paresthesia, Pulselessness, Paralysis, and Poikilothermia. * **Gold Standard Diagnosis:** Clinical exam; however, a compartment pressure **>30 mmHg** is diagnostic.

Q: Which of the following is NOT a risk factor for contrast nephropathy?

Half normal saline. **Explanation:** Contrast-Induced Nephropathy (CIN) is a form of acute kidney injury occurring after the intravascular administration of iodinated contrast media. The pathophysiology involves direct tubular toxicity and renal medullary ischemia. **Why Half Normal Saline (0.45% NaCl) is the correct answer:** Half normal saline is **not** a risk factor; rather, it was historically used for prevention. However, current clinical guidelines (such as ESUR and ACR) emphasize that **Isotonic Saline (0.9% NaCl)** or Isotonic Sodium Bicarbonate are the most effective agents for volume expansion to prevent CIN. While 0.45% saline is less effective than 0.9% saline, it is a preventive strategy, not a causative risk factor. **Analysis of Incorrect Options (Risk Factors):** * **Metformin:** While Metformin does not directly cause CIN, it is excreted renally. If CIN occurs, Metformin accumulates, leading to life-threatening **Lactic Acidosis**. It must be withheld for 48 hours post-procedure in high-risk patients. * **Dehydration:** Hypovolemia reduces renal perfusion and increases the concentration of contrast in the tubules, significantly elevating the risk of toxicity. * **NSAIDs:** These drugs inhibit prostaglandin-mediated vasodilation of the afferent arteriole, worsening renal ischemia when combined with contrast media. **High-Yield Clinical Pearls for NEET-PG:** * **Definition of CIN:** An increase in serum creatinine >0.5 mg/dL or >25% from baseline within 48–72 hours of contrast administration. * **Most Important Risk Factor:** Pre-existing renal insufficiency (especially Diabetic Nephropathy). * **Best Preventive Measure:** Adequate pre-procedural hydration with **Isotonic Saline (0.9% NaCl)**. * **Contrast Choice:** Low-osmolar (LOCM) or Iso-osmolar contrast media (IOCM) are preferred over high-osmolar agents to reduce risk.

An 18-year-old woman develops urticaria and wheezing after an injection of intravenous contrast for an abdominal CT scan. Her blood pressure is 120/60 mm Hg, heart rate is 155 beats per minute, and respiratory rate is 30 breaths per minute. Which of the following is the most appropriate immediate therapy?

Q10Easy

Which of the following is NOT a risk factor for contrast nephropathy?

Contrast Media and Reactions Indian Medical PG Practice Questions and MCQs

Question 1: All of the following are used in a patient with decreased renal function (reduced GFR) to avoid contrast nephropathy except?

A. N-acetyl cysteine
B. Mannitol (Correct Answer)
C. Fenoldopam
D. Low osmolar contrast media (LOCM)

Explanation: **Explanation:** Contrast-Induced Nephropathy (CIN) is a significant risk in patients with reduced GFR. The goal of management is to minimize renal vasoconstriction and oxidative stress. **Why Mannitol is the Correct Answer:** Historically, diuretics like **Mannitol** and Furosemide were thought to "flush" the kidneys. However, clinical trials (such as the PRINCE study) have shown that Mannitol is **ineffective** and may actually be **harmful**. It can cause osmotic diuresis leading to dehydration and further renal vasoconstriction, potentially worsening the risk of CIN. Therefore, it is no longer recommended. **Analysis of Other Options:** * **N-acetyl cysteine (NAC):** An antioxidant that scavenges free radicals and induces vasodilation. While its efficacy is debated in recent large trials (PRESERVE), it is still traditionally used in protocols to prevent CIN due to its low cost and safety profile. * **Fenoldopam:** A selective dopamine D1 receptor agonist that causes renal vasodilation. Though not routinely used due to cost and mixed evidence, it is pharmacologically intended to increase renal blood flow. * **Low Osmolar Contrast Media (LOCM):** High osmolar contrast (HOCM) is highly nephrotoxic. Switching to LOCM (e.g., Iohexol) or Iso-osmolar contrast (e.g., Iodixanol) significantly reduces the risk of CIN in high-risk patients. **High-Yield Clinical Pearls for NEET-PG:** * **Most effective preventive measure:** Adequate **Pre-procedure Hydration** with 0.9% Normal Saline is the gold standard. * **Definition of CIN:** An increase in serum creatinine of >0.5 mg/dL or >25% from baseline within 48–72 hours of contrast administration. * **Metformin:** Must be withheld for 48 hours *after* the procedure to avoid lactic acidosis if renal failure occurs.

Question 2: Which of the following conditions is associated with contrast nephropathy?

A. Diabetes nephropathy (Correct Answer)
B. Hypertension
C. Malignant hypertension
D. Hypertensive glomerulosclerosis

Explanation: **Explanation:** **Contrast-Induced Nephropathy (CIN)** is defined as an acute impairment of renal function (an increase in serum creatinine by >25% or >0.5 mg/dL) occurring within 48–72 hours of intravascular contrast administration. **Why Diabetes Nephropathy is the Correct Answer:** Diabetes mellitus, particularly when associated with pre-existing renal insufficiency (**Diabetic Nephropathy**), is the **single most significant independent risk factor** for developing CIN. The pathophysiology involves contrast-induced renal vasoconstriction leading to medullary ischemia and direct tubular cytotoxicity. In diabetic patients, the baseline oxidative stress and impaired vasodilatory capacity of the renal vasculature significantly potentiate these effects. **Analysis of Incorrect Options:** * **B, C, and D (Hypertension, Malignant Hypertension, Hypertensive Glomerulosclerosis):** While chronic hypertension can lead to renal damage, it is generally considered a secondary risk factor. Hypertension only significantly increases the risk of CIN if it has already progressed to significant **chronic kidney disease (CKD)** with a reduced Glomerular Filtration Rate (GFR). Diabetic nephropathy carries a much higher relative risk compared to hypertensive nephrosclerosis alone. **High-Yield Clinical Pearls for NEET-PG:** * **Most Important Risk Factor:** Pre-existing renal insufficiency (low GFR). * **Most Effective Prophylaxis:** Intravenous hydration with **Isotonic Saline (0.9% NaCl)** or Sodium Bicarbonate before and after the procedure. * **Metformin Warning:** Metformin does not cause CIN, but if CIN occurs, Metformin can accumulate and cause **Lactic Acidosis**. It should be withheld for 48 hours after contrast administration. * **Contrast Choice:** Non-ionic, **iso-osmolar** contrast media (e.g., Iodixanol) carry the lowest risk for nephropathy.

Question 3: Which of the following investigations must be performed before administering contrast to a patient?

A. Kidney function test (KFT) (Correct Answer)
B. Liver function test (LFT)
C. Urine specific gravity
D. Serum electrolytes

Explanation: **Explanation:** The administration of iodinated contrast media (used in CT scans and angiography) poses a significant risk of **Contrast-Induced Nephropathy (CIN)**. CIN is defined as an acute decline in renal function (increase in serum creatinine by >0.5 mg/dL or >25% from baseline) within 48–72 hours of contrast exposure. Therefore, assessing the **Kidney Function Test (KFT)**—specifically **Serum Creatinine** and the **estimated Glomerular Filtration Rate (eGFR)**—is mandatory to screen for pre-existing renal impairment, which is the strongest risk factor for CIN. **Analysis of Incorrect Options:** * **Liver Function Test (LFT):** While some contrast agents are excreted via the biliary system, hepatic impairment does not significantly increase the risk of acute toxicity or contrast reactions. * **Urine Specific Gravity:** This measures urine concentration and hydration status but is an unreliable indicator of the kidney's ability to clear contrast media compared to eGFR. * **Serum Electrolytes:** While important for general patient management, electrolyte imbalances are not a direct contraindication to contrast nor a primary predictor of contrast-induced injury. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Threshold:** Contrast is generally considered safe if **eGFR >60 mL/min/1.73m²**. Caution is required if eGFR is between 30–60, and it is generally avoided (unless emergency) if **eGFR <30**. * **Prevention:** The most effective preventive measure for CIN is **intravenous hydration** with 0.9% Normal Saline before and after the procedure. * **Metformin:** In patients with renal impairment, Metformin should be withheld for 48 hours after contrast administration to prevent **Lactic Acidosis**. * **MRI Contrast:** For Gadolinium-based agents, the concern is **Nephrogenic Systemic Fibrosis (NSF)** in patients with severe renal failure.

Question 4: All of the following are true about iodinated intravascular contrast media except –

A. They are used in digital subtraction angiography
B. They are radio opaque
C. They can cause anaphylactic reactions
D. They are used in magnetic resonance imaging (Correct Answer)

Explanation: **Explanation:** The correct answer is **D**. Iodinated contrast media are specifically designed for X-ray-based imaging modalities, not Magnetic Resonance Imaging (MRI). **1. Why Option D is the correct (false) statement:** Iodinated contrast agents work by increasing the attenuation of X-ray beams due to the high atomic number of Iodine ($Z=53$). MRI does not use X-rays; instead, it utilizes magnetic fields and radiofrequency pulses. The standard contrast agents for MRI are **Gadolinium-based contrast agents (GBCAs)**, which are paramagnetic and work by altering the relaxation times ($T1$ and $T2$) of nearby water protons. **2. Analysis of incorrect (true) options:** * **Option A:** Digital Subtraction Angiography (DSA) uses iodinated contrast injected into vessels to visualize lumen morphology by "subtracting" the overlying bone and soft tissue densities. * **Option B:** Iodine is highly **radio-opaque** (appears white on imaging) because it absorbs X-ray photons, providing the necessary contrast against blood and soft tissues. * **Option C:** These agents can cause **idiosyncratic (anaphylactoid) reactions**, ranging from mild urticaria to life-threatening bronchospasm and shock. Unlike true allergies, these are often not IgE-mediated. **Clinical Pearls for NEET-PG:** * **Contrast-Induced Nephropathy (CIN):** A key risk factor; defined as an increase in serum creatinine >0.5 mg/dL or >25% from baseline within 48–72 hours of administration. * **Pre-medication:** For patients with a history of prior reactions, use corticosteroids (e.g., Prednisolone) and H1 blockers. * **Osmolality:** Non-ionic, low-osmolar contrast media (LOCM) are preferred over high-osmolar media (HOCM) as they are safer and better tolerated. * **MRI Exception:** While rare, **Hepatobiliary agents** (like Primovist) are used in MRI, but they are still Gadolinium-based, never iodinated.

Question 5: Nephrogenic systemic fibrosis is associated with:

A. Gadolinium administration in patients with chronic renal failure (Correct Answer)
B. Genetic disease with selenium deficiency
C. Chromium toxicity
D. HIV association

Explanation: **Explanation:** **Nephrogenic Systemic Fibrosis (NSF)** is a rare but serious systemic disorder characterized by widespread fibrosis of the skin, joints, eyes, and internal organs. 1. **Why Option A is Correct:** NSF is strongly associated with the administration of **Gadolinium-based contrast agents (GBCAs)** in patients with severe renal impairment (typically a GFR <30 mL/min/1.73m²). In patients with chronic renal failure, the delayed excretion of Gadolinium allows the ion to dissociate from its chelate (transmetallation). The free Gadolinium then deposits in tissues, triggering an inflammatory response and excessive collagen deposition by fibrocytes. 2. **Why Other Options are Incorrect:** * **Option B:** Selenium deficiency is associated with **Keshan disease** (a cardiomyopathy), not systemic fibrosis. * **Option C:** Chromium toxicity typically leads to acute tubular necrosis or contact dermatitis, but it has no known link to NSF. * **Option D:** While HIV patients may have renal issues, NSF is specifically a contrast-induced pathology, not a direct manifestation of viral infection. **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors:** Most common with **linear** non-ionic chelates (e.g., Gadodiamide) compared to macrocyclic agents. * **Clinical Presentation:** "Woody" induration of the skin, usually starting on the extremities and sparing the face. * **Prevention:** Always check **Serum Creatinine/eGFR** before administering Gadolinium. * **Management:** There is no proven cure; prevention is key. Hemodialysis immediately after contrast administration may help but does not guarantee prevention.

Question 6: Which of the following contrast media agents is least nephrotoxic?

A. Iodixanol (Correct Answer)
B. Diatrizoate
C. Metrizoate
D. Ioxaglate

Explanation: ### Explanation The primary determinant of contrast-induced nephropathy (CIN) is the **osmolality** of the contrast medium. High-osmolality agents cause renal vasoconstriction and direct tubular toxicity. **1. Why Iodixanol is Correct:** Iodixanol is a **non-ionic dimer** and is classified as an **Iso-osmolar Contrast Medium (IOCM)**. Its osmolality (approx. 290 mOsm/kg) is equal to that of human blood. Because it is isotonic to plasma, it causes the least amount of osmotic stress on the renal tubules, making it the least nephrotoxic option among those listed, especially in high-risk patients (e.g., diabetics with pre-existing renal impairment). **2. Analysis of Incorrect Options:** * **Diatrizoate & Metrizoate (Option B & C):** These are **Ionic Monomers** classified as **High-Osmolar Contrast Media (HOCM)**. Their osmolality is 5–8 times that of plasma (1500–2000 mOsm/kg). They carry the highest risk of nephrotoxicity and adverse allergic reactions. * **Ioxaglate (Option D):** This is an **Ionic Dimer** classified as a **Low-Osmolar Contrast Medium (LOCM)**. While safer than HOCM, its ionic nature and higher osmolality compared to Iodixanol make it more nephrotoxic than iso-osmolar agents. **3. NEET-PG High-Yield Pearls:** * **Classification by Osmolality:** * **HOCM:** Diatrizoate, Metrizoate, Iothalamate. * **LOCM:** Iohexol, Iopromide, Ioversol, Ioxaglate (Ionic). * **IOCM:** Iodixanol (Safest for kidneys). * **CIN Prevention:** The most effective preventive measure is **adequate hydration** (Normal saline) before and after the procedure. * **Risk Factor:** A baseline Serum Creatinine >1.5 mg/dL or eGFR <60 mL/min increases the risk of CIN. * **Metformin Rule:** Metformin should be withheld for 48 hours *after* contrast administration to prevent lactic acidosis if renal failure occurs.

Question 7: Worsening of kidney function in contrast nephropathy is best evaluated with?

A. High serum creatinine (Correct Answer)
B. Low serum creatinine
C. High serum bilirubin
D. Low serum bilirubin

Explanation: **Explanation:** **Contrast-Induced Nephropathy (CIN)** is defined as an acute impairment of renal function following the intravascular administration of iodinated contrast media. **1. Why High Serum Creatinine is Correct:** Serum creatinine is the standard biochemical marker used to monitor glomerular filtration rate (GFR). In CIN, the contrast medium causes renal vasoconstriction and direct tubular toxicity, leading to a decrease in GFR. This results in a **rise in serum creatinine**, typically peaking within 3 to 5 days after contrast administration. A common diagnostic criterion for CIN is an absolute increase in serum creatinine of **≥0.5 mg/dL** or a relative increase of **≥25%** from the baseline value within 48–72 hours. **2. Why Incorrect Options are Wrong:** * **Low Serum Creatinine:** A decrease in creatinine would indicate improving renal function or muscle wasting, which is the opposite of what occurs in nephropathy. * **High/Low Serum Bilirubin:** Bilirubin is a marker of hepatobiliary function and hemolysis. It has no physiological correlation with contrast-induced renal injury or glomerular filtration. **Clinical Pearls for NEET-PG:** * **Risk Factor:** The single most important risk factor for CIN is pre-existing **chronic kidney disease (CKD)**, especially when associated with Diabetes Mellitus. * **Prevention:** The most effective preventive strategy is **adequate hydration** (usually with 0.9% Normal Saline) before and after the procedure. * **Contrast Choice:** Using **Non-ionic, Low-osmolar (LOCM)** or **Iso-osmolar** contrast media reduces the risk of CIN compared to high-osmolar agents. * **Metformin Note:** Metformin does not cause CIN, but if CIN occurs, metformin can accumulate and cause **lactic acidosis**. It should be withheld for 48 hours after the procedure in high-risk patients.

Question 8: A child undergoing CECT chest develops immediate swelling at the contrast injection site, progressing gradually. The child also reports numbness and pain on passive finger extension, and examination reveals a feeble radial pulse. What is the most appropriate next step?

A. High dose prednisolone and antihistamines
B. Angiography
C. Immediate fasciotomy (Correct Answer)
D. Surgical exploration

Explanation: ### Explanation The clinical presentation describes a severe case of **Contrast Extravasation** leading to **Acute Compartment Syndrome**. **1. Why "Immediate Fasciotomy" is Correct:** The key clinical markers here are **pain on passive extension**, **numbness** (paresthesia), and a **feeble radial pulse**. These are the "Ps" of compartment syndrome. When contrast is injected under pressure (especially via power injectors in CECT), a large volume can enter the tight fascial compartments of the limb. This increases intracompartmental pressure, compromising capillary perfusion and leading to tissue ischemia. If neurovascular compromise is evident (feeble pulse, sensory loss), it is a surgical emergency requiring **immediate fasciotomy** to decompress the compartment and prevent permanent necrosis or Volkmann’s Ischemic Contracture. **2. Why Other Options are Incorrect:** * **A. High dose prednisolone and antihistamines:** These are used for *anaphylactoid* (hypersensitivity) reactions. They do not address the mechanical pressure/ischemia caused by extravasation. * **B. Angiography:** This would cause further delay and potentially involve more contrast injection, worsening the pressure. Diagnosis of compartment syndrome is primarily clinical. * **D. Surgical exploration:** While related, "exploration" is too vague. The specific life-and-limb-saving procedure required for compartment syndrome is a fasciotomy. **3. Clinical Pearls for NEET-PG:** * **Risk Factors:** Use of power injectors, small/fragile veins (infants/elderly), and unconscious patients who cannot report pain. * **Initial Management:** For *mild* extravasation, elevate the limb and apply cold compresses. * **The "6 Ps" of Compartment Syndrome:** Pain (out of proportion), Pallor, Paresthesia, Pulselessness, Paralysis, and Poikilothermia. * **Gold Standard Diagnosis:** Clinical exam; however, a compartment pressure **>30 mmHg** is diagnostic.

Question 9: An 18-year-old woman develops urticaria and wheezing after an injection of intravenous contrast for an abdominal CT scan. Her blood pressure is 120/60 mm Hg, heart rate is 155 beats per minute, and respiratory rate is 30 breaths per minute. Which of the following is the most appropriate immediate therapy?

A. Intubation
B. Epinephrine (Correct Answer)
C. Beta-blockers
D. Iodine

Explanation: ### Explanation The patient is presenting with a **moderate to severe anaphylactoid reaction** to intravenous contrast, characterized by cutaneous symptoms (urticaria) and respiratory distress (wheezing, tachypnea). Despite the stable blood pressure, the presence of tachycardia (155 bpm) and respiratory compromise necessitates immediate intervention. **Why Epinephrine is Correct:** Epinephrine is the **drug of choice** for anaphylactic/anaphylactoid reactions. It acts as an alpha-1 agonist (reducing mucosal edema and increasing BP), beta-1 agonist (increasing cardiac output), and beta-2 agonist (causing bronchodilation). In this case, it addresses both the bronchospasm (wheezing) and the potential for rapid circulatory collapse. For contrast reactions, it is typically administered intramuscularly (1:1000) or intravenously (1:10,000) depending on the severity and presence of hypotension. **Why the Other Options are Incorrect:** * **Intubation:** While airway management is crucial, it is an invasive step reserved for patients with impending airway obstruction (laryngeal edema) or respiratory failure not responding to medical therapy. Epinephrine is the first-line pharmacological step. * **Beta-blockers:** These are **contraindicated**. They would worsen bronchospasm and could lead to refractory hypotension by blocking the compensatory tachycardia and the effects of endogenous or exogenous epinephrine. * **Iodine:** This is a component of the contrast agent itself, not a treatment. Contrast reactions are idiosyncratic and not typically a "true" IgE-mediated allergy to iodine. **High-Yield Clinical Pearls for NEET-PG:** * **Classification:** Contrast reactions are divided into **Idiosyncratic** (unpredictable, anaphylactoid) and **Non-idiosyncratic** (chemotoxic, e.g., contrast-induced nephropathy). * **Pre-medication:** For high-risk patients, use **Corticosteroids** (e.g., Prednisolone 50mg) 6–12 hours before the procedure and H1-antihistamines. * **Risk Factor:** The single greatest risk factor for a contrast reaction is a **previous reaction** to the same contrast medium. * **LOCM vs. HOCM:** Low Osmolar Contrast Media (LOCM) have a significantly lower incidence of adverse reactions compared to High Osmolar Contrast Media (HOCM).

Question 10: Which of the following is NOT a risk factor for contrast nephropathy?

A. Metformin
B. Dehydration
C. NSAIDs
D. Half normal saline (Correct Answer)

Explanation: **Explanation:** Contrast-Induced Nephropathy (CIN) is a form of acute kidney injury occurring after the intravascular administration of iodinated contrast media. The pathophysiology involves direct tubular toxicity and renal medullary ischemia. **Why Half Normal Saline (0.45% NaCl) is the correct answer:** Half normal saline is **not** a risk factor; rather, it was historically used for prevention. However, current clinical guidelines (such as ESUR and ACR) emphasize that **Isotonic Saline (0.9% NaCl)** or Isotonic Sodium Bicarbonate are the most effective agents for volume expansion to prevent CIN. While 0.45% saline is less effective than 0.9% saline, it is a preventive strategy, not a causative risk factor. **Analysis of Incorrect Options (Risk Factors):** * **Metformin:** While Metformin does not directly cause CIN, it is excreted renally. If CIN occurs, Metformin accumulates, leading to life-threatening **Lactic Acidosis**. It must be withheld for 48 hours post-procedure in high-risk patients. * **Dehydration:** Hypovolemia reduces renal perfusion and increases the concentration of contrast in the tubules, significantly elevating the risk of toxicity. * **NSAIDs:** These drugs inhibit prostaglandin-mediated vasodilation of the afferent arteriole, worsening renal ischemia when combined with contrast media. **High-Yield Clinical Pearls for NEET-PG:** * **Definition of CIN:** An increase in serum creatinine >0.5 mg/dL or >25% from baseline within 48–72 hours of contrast administration. * **Most Important Risk Factor:** Pre-existing renal insufficiency (especially Diabetic Nephropathy). * **Best Preventive Measure:** Adequate pre-procedural hydration with **Isotonic Saline (0.9% NaCl)**. * **Contrast Choice:** Low-osmolar (LOCM) or Iso-osmolar contrast media (IOCM) are preferred over high-osmolar agents to reduce risk.

Practice by Chapter

Chemistry of Contrast Media

Practice Questions

Pharmacokinetics of Contrast Agents

Practice Questions

Classification of Contrast Reactions

Practice Questions

Risk Factors for Contrast Reactions

Practice Questions

Prevention of Contrast Reactions

Practice Questions

Treatment of Acute Contrast Reactions

Practice Questions

Contrast-Induced Nephropathy

Practice Questions

Nephrogenic Systemic Fibrosis

Practice Questions

Extravasation of Contrast Media

Practice Questions

Guidelines for Contrast Administration

Practice Questions

Alternative Contrast Agents

Practice Questions

Documentation and Medicolegal Aspects

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free